NDC 51672-1360-01 - Acyclovir
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1360
- Requested NDC
- 51672-1360-01
- Package NDCs from labels
- 51672-1360-1, 51672-1360-2, 51672-1360-5, 51672-1360-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc.
- Effective date
- 2025-09-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Acyclovir Ointment USP, 5% | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2025-09-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1360-1 | Acyclovir | 15 g in 1 TUBE | OINTMENT | 15 | 5 | |
| 51672-1360-1 | Acyclovir | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-1360-2 | Acyclovir | 30 g in 1 TUBE | OINTMENT | 30 | 5 | |
| 51672-1360-2 | Acyclovir | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-1360-5 | Acyclovir | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-1360-5 | Acyclovir | 5 g in 1 TUBE | OINTMENT | 5 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1360 | ACYCLOVIR OINTMENT [SUN PHARMACEUTICAL INDUSTRIES, INC.] | 3 | Current NDC, Legacy NDC, 6 package rows | 20250406_962b2e1a-ba9d-4b39-b6d1-203947166482.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-1360-1 | GM - Gram | 51672-1360 | 03d1dfa6-12c1-4688-8c5e-6082116aa76f | 1 | 2017-03-06 |
| 51672-1360-2 | GM - Gram | 51672-1360 | 3ab83581-69ee-40d4-bb74-dd7af371494a | 1 | 2017-03-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ACYCLOVIR | ACYCLOVIR | Bryant Ranch Prepack | e5356160-cb35-4ff6-91d5-2ade594e0279 | 2026-03-25 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | 69e5455e-d0be-4c2b-b9ab-458b5480ed57 | 2026-03-16 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 8fdabab2-bc93-48ab-9c13-d22ec90fdcfc | 2026-02-27 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Florida Pharmaceutical Products, LLC | 3df7fa38-a869-45fb-98a3-81c5a2527d62 | 2026-02-18 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Major Pharmaceuticals | 46150f19-ce5d-42a0-80a7-f96fda2b9879 | 2026-02-18 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Preferred Pharmaceuticals, Inc. | b6d69697-12bb-4548-a6c3-2463cbf54f8f | 2026-02-11 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | A-S Medication Solutions | 2e6a3667-af06-40de-80c0-8c4346e0671f | 2026-02-08 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Camber Pharmaceuticals, Inc. | 0910335b-6796-459f-b97e-d7ef5439a060 | 2026-02-02 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | Glenmark Pharmaceuticals Inc., USA | 149f4418-7668-4d34-a6f9-69bf3a9c5049 | 2026-01-28 | Warnings, Adverse reactions | 197312 X4HES1O11F |
| acyclovir | ACYCLOVIR | ANI Pharmaceuticals, Inc. | 8208711c-18ba-4615-b932-3c0bb7e6efae | 2026-01-23 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Actavis Pharma, Inc. | a4c1305c-f18c-4fb0-83d8-2822341f2dfa | 2026-01-21 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Preferred Pharmaceuticals Inc | 75334fc5-d236-401a-875c-f4f9c7749c1a | 2026-01-19 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | Preferred Pharmaceuticals Inc | c11c1136-7421-48ff-86d2-39507e80a04c | 2026-01-15 | Warnings, Adverse reactions | 197312 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Preferred Pharmaceuticals Inc. | b1033fda-8242-4006-b1cd-23474d70671f | 2026-01-15 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | AvPAK | 6e203fa9-ee97-1e08-8d6a-fb57cfa13e19 | 2026-01-08 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Cadila Pharmaceuticals Limited | dbaf4bf5-57e3-4770-a9b2-d47649e54c1b | 2026-01-02 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Northwind Health Company, LLC | 5dcfd21c-43f0-469c-be70-a4e74e6ccf88 | 2026-01-01 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Northwind Health Company, LLC | f6f56143-ea74-af87-e053-6394a90ae346 | 2026-01-01 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | Northwind Health Company, LLC | ff9776b3-a248-e1ea-e053-6294a90aeb7b | 2026-01-01 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | YILING PHARMACEUTICAL, INC. | 67e7b340-0635-2595-e053-2a91aa0ad266 | 2025-12-30 | Warnings, Adverse reactions | X4HES1O11F |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.